See How Many Clients You're Missing Each Month

Simply enter your business email & Topline AI Agent will show you.

Matthias Fehr profile image

Matthias Fehr

Head Private Equity at HBM Partners
Intro Book
Experienced investment professional with 21+ years of experience in private equity, venture capital, and pharmaceutical industries.
  • Claim this Profile
Location
Zurich, Switzerland, CH
Languages
  • English Professional working proficiency
  • German Native or bilingual proficiency
  • French Professional working proficiency
  • Italian Professional working proficiency
  • Catalan Professional working proficiency
  • Spanish Professional working proficiency
Skills
  • Private Equity
  • Mergers And Acquisitions
  • Due Diligence
  • Ipo
  • Business Development
  • Show all
image
image

Refer a Friend to Get
100 Credits For FREE

Refer a Friend Now

Bio

Generated by
Topline AI
Matthias Fehr is a seasoned investment professional with 21+ years of experience in private equity, venture capital, and pharmaceutical industries. He holds a PhD in Chemistry from ETH Zürich and is a CFA charterholder. Fehr has worked with top-tier firms, including HBM Partners, Lombard Odier, and Credit Suisse, advising on investments and M&A transactions.

Experience

  • HBM Partners
    • Zürich Area, Switzerland
    • Head Private Equity
      • Aug 2002 - Present
      • Zürich Area, Switzerland

      2007 - today Investor for Growth Equity Private Equity and Venture Investments2020: ALX Oncology, US, VC (IPO in 2020)2018: sphingotec, Berlin, VC , Series A (EUR 20m Round) 2017: Harmony Biosciences, US, VC, Series A ($30m Investment2017: Complexa, US, VC, Series C ($ 5m Investment)2017: Shriji Polymers, India, ($3m Investment)2017: Forbius, Canada, Venture Capital, Series B2017: Swixx Biopharma, CH, Growth Equity Minority (EUR 20m investment - Board Member)2016: Neurelis Inc., US - San Diego, Venture Capital ($ 8m)2016-2017: True North Therapeutics, US - SFO, Venture Capital ($ 10m) - May 2017: Acquired by Bioverativ2016: Armo Biosciences, US - San Francisco, Venture Capital ($10m)2016: Iconic Therapeutics, US - San Francisco, Venture Capital (USD 7.5m - Board Observer)2015: Wuxi Healthcare Ventures II, US/China Healthcare Venture Fund, $20m Committment2014: Farmalatam, Latam, Online Pharmacy & Digital HC, VC (Board Member)2014: AAA, France, Growth Equity, Radiopharma (EUR 25m - Board Observer). Additional investments in Mezzanine round and IPO in 2015.2007 - 2011: PharmaSwiss, CH, Growth Equity (EUR 56m, Board Observer). Trade Sale to Valeant in 2011.2002 - 2007 Investment Advisor for Public Equity InvestmentsPIPEs Rigel Phamaceuticals and Depomed ($ 5m each in 2003)2003 - today Investment Advisor for Indian InvestmentsInvestments led: 1mg (India's largest online pharmacy, Board Observer), Sai Life Sciences (Leading India based CRAMS, Board Observer)2009 - today Investment Advisor for Tata Capital HBM Healthcare Fund (Indian PE Fund,$ 10m)Tata Capital HBM Healthcare Investment I Fund invested in 6 companies from 2014-2017

  • Lombard Odier
    • Zurich and Geneva
    • Senior Sell-Side Analyst
      • Oct 1998 - Jul 2002
      • Zurich and Geneva

      Sell-side research for Healthcare Industry (Medical Technology, Pharmaceuticals, Biotechnology and Services). Covered companies included: Roche, Novartis, Serono, Actelion, Cytos, Galenica, Straumann, Disetronic, Phonak, Lonza, Siegfried, Oridion, Card Guard, SHL Telemedicine, Synthes-Stratec, Sulzer Medica

  • Credit Suisse
    • Zürich Area, Switzerland
    • Business Development Manager
      • 1997 - Oct 1998
      • Zürich Area, Switzerland

Education

  • 2001 - 2003
    CFA Institute
    CFA, Financial Education
  • 1994 - 1997
    ETH Zürich
    PhD, Chemistry
  • 1990 - 1994
    ETH Zürich
    MSc, Chemistry

Suggested Services

This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection

Industry Focus. “Investment Management”

Looking to Create a Custom Project?

Need a custom project? We'll create a solution designed specifically for your project.

Get Started

References

Social Profiles

Community

You need to have a working account to view this content. Click here to join now

Similar Profiles